Lantheus Holdings (LNTH)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Lantheus Holdings (LNTH)
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
Key Insights
Critical company metrics and information
Share Price
$88.51Market Cap
$6.15 BillionTotal Outstanding Shares
69.53 Million SharesTotal Employees
834Dividend
No dividendIPO Date
June 25, 2015SIC Description
In Vitro & In Vivo Diagnostic SubstancesHomepage
https://www.lantheus.com
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities | $-15.33 Million |
| Net Cash Flow | $252.30 Million |
| Net Cash Flow From Financing Activities, Continuing | $-15.33 Million |
| Exchange Gains/Losses | $198000.00 |
| Net Cash Flow From Investing Activities, Continuing | $-231.48 Million |
| Net Cash Flow From Operating Activities, Continuing | $499.31 Million |
| Net Cash Flow From Operating Activities | $499.31 Million |
| Net Cash Flow, Continuing | $252.50 Million |
| Net Cash Flow From Investing Activities | $-231.48 Million |
Income Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Income Tax Expense/Benefit | $142.55 Million |
| Net Income/Loss Available To Common Stockholders, Basic | $427.61 Million |
| Diluted Earnings Per Share | $6.00 |
| Costs And Expenses | $926.64 Million |
| Income/Loss From Continuing Operations After Tax | $427.61 Million |
| Benefits Costs and Expenses | $926.64 Million |
| Research and Development | $149.60 Million |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Income/Loss From Continuing Operations Before Tax | $570.16 Million |
| Cost Of Revenue | $527.18 Million |
| Gross Profit | $969.62 Million |
| Operating Income/Loss | $480.59 Million |
| Operating Expenses | $489.02 Million |
| Net Income/Loss Attributable To Parent | $427.61 Million |
| Revenues | $1.50 Billion |
| Other Operating Expenses | $339.43 Million |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Net Income/Loss | $427.61 Million |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Diluted Average Shares | $143.40 Million |
| Basic Average Shares | $138.60 Million |
| Basic Earnings Per Share | $6.21 |
Balance Sheet
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Equity Attributable To Parent | $1.18 Billion |
| Liabilities | $869.92 Million |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Wages | $35.74 Million |
| Liabilities And Equity | $2.05 Billion |
| Other Non-current Assets | $410.80 Million |
| Intangible Assets | $173.61 Million |
| Other Current Assets | $1.22 Billion |
| Accounts Payable | $44.91 Million |
| Other Current Liabilities | $703.42 Million |
| Assets | $2.05 Billion |
| Fixed Assets | $169.51 Million |
| Inventory | $70.83 Million |
| Current Liabilities | $784.08 Million |
| Equity | $1.18 Billion |
| Noncurrent Liabilities | $85.84 Million |
| Noncurrent Assets | $753.92 Million |
| Current Assets | $1.30 Billion |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.